TruDataRx utilizes Comparative Effectiveness Research to analyze clinical data, enabling employers to identify the most effective medications at the lowest cost. This approach can reduce pharmacy benefit spending by 20-40% while improving the clinical value of covered drugs.
Funding
$280K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Employers face rising prescription drug costs without clear insight into the clinical value of the medications they cover. Traditional pharmacy benefit management often lacks transparency, leading to suboptimal formulary choices and unnecessary expenses. A reliance on rebates and a lack of comparative effectiveness data further exacerbate the problem.
Solution
TruDataRx leverages Comparative Effectiveness Research (CER) to analyze clinical data and identify the most effective medications at the lowest cost. By evaluating the clinical value of covered drugs, TruDataRx enables employers to make informed decisions about their pharmacy benefits. Their independent approach ensures unbiased recommendations, free from industry incentives, that align with the employer's goals of keeping members healthy while reducing overall prescription spending. TruDataRx's Clinical Pharmacy Navigators communicate directly with members to ensure a positive experience and understanding of their medication options.
Target Audience
The primary target audience is employers seeking to reduce pharmacy benefit spending while improving the clinical value of covered drugs, as well as commercial ACOs looking to optimize their pharmacy spend.
Features
- Comparative Effectiveness Research to determine the most effective drugs at the lowest cost.
- Identification of generic-to-generic switches with best clinical effectiveness and lowest cost.
- Analysis of specialty medications to ensure high value coverage.
- Detection of overpriced generic medications with lower-cost alternatives.
- Evidence-based algorithms built using established and cutting-edge CER.
- Expert client implementation team to translate approved changes into action with PBMs or other vendors.
- Clinical Pharmacy Navigators to communicate clinical data to members.